Literature DB >> 1647138

Pneumonitis associated with coinfection by human herpesvirus 6 and Legionella in an immunocompetent adult.

S K Russler1, M A Tapper, K K Knox, A Liepins, D R Carrigan.   

Abstract

The authors report a case of pneumonitis in a young healthy man caused by coinfection with human herpesvirus 6 (HHV-6) and Legionella pneumophila. The patient's course was complicated by severe respiratory, renal, hepatic, and central nervous system dysfunctions, which were believed to be primarily the results of his Legionella infection. Aggressive antibiotic treatment produced no response, and Legionella remained isolatable from lung tissue throughout several weeks of antimicrobial therapy. Human herpesvirus 6 was isolated from a sample of peripheral blood during the acute stage of the patient's illness, and numerous HHV-6--infected macrophages and lymphocytes were detected by immunohistochemical staining of biopsy-derived lung tissue. Paradoxically treatment of the patient with high-dose corticosteroids resulted in dramatic improvement of his condition, including clearance of the Legionella infection. The demonstration that corticosteroids efficiently inhibit HHV-6 replication in vitro suggests that the virus may have contributed to the patient's pneumonitis by enhancing tissue inflammation, by compromising the function of pulmonary macrophages, and, perhaps, by destroying the patient's CD4+ T lymphocytes. Human herpesvirus 6 may be able to function as a synergistic cofactor in lung infections by Legionella and other pathogens.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1647138      PMCID: PMC1886405     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  30 in total

1.  Fatal fulminant hepatitis in an infant with human herpesvirus-6 infection.

Authors:  Y Asano; T Yoshikawa; S Suga; T Yazaki; K Kondo; K Yamanishi
Journal:  Lancet       Date:  1990-04-07       Impact factor: 79.321

Review 2.  The status of CMV as a human pathogen.

Authors:  P D Griffiths; J E Grundy
Journal:  Epidemiol Infect       Date:  1988-02       Impact factor: 2.451

3.  Cellular immunity after intravenous administration of methylprednisolone.

Authors:  M L Webel; R E Ritts; H F Taswell; J V Danadio; J E Woods
Journal:  J Lab Clin Med       Date:  1974-03

4.  Human herpesvirus 6 infection in renal transplantation.

Authors:  T Okuno; K Higashi; K Shiraki; K Yamanishi; M Takahashi; Y Kokado; M Ishibashi; S Takahara; T Sonoda; K Tanaka
Journal:  Transplantation       Date:  1990-03       Impact factor: 4.939

5.  Isolation of a new human herpesvirus producing a lytic infection of helper (CD4) T-lymphocytes in peripheral blood lymphocyte cultures--another cause of acquired immunodeficiency?

Authors:  W B Becker; S Engelbrecht; M L Becker; C Piek; B A Robson; L Wood; P Jacobs
Journal:  S Afr Med J       Date:  1988-12-17

6.  T-cell activation is required for efficient replication of human herpesvirus 6.

Authors:  N Frenkel; E C Schirmer; G Katsafanas; C H June
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

7.  Persistent fatigue and depression in patient with antibody to human B-lymphotropic virus.

Authors:  G R Krueger; B Koch; D V Ablashi
Journal:  Lancet       Date:  1987-07-04       Impact factor: 79.321

8.  Frequent isolation of HHV-6 from saliva and high seroprevalence of the virus in the population.

Authors:  J A Levy; F Ferro; D Greenspan; E T Lennette
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

9.  Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders.

Authors:  S Z Salahuddin; D V Ablashi; P D Markham; S F Josephs; S Sturzenegger; M Kaplan; G Halligan; P Biberfeld; F Wong-Staal; B Kramarsky
Journal:  Science       Date:  1986-10-31       Impact factor: 47.728

10.  In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus-6).

Authors:  P Lusso; P D Markham; E Tschachler; F di Marzo Veronese; S Z Salahuddin; D V Ablashi; S Pahwa; K Krohn; R C Gallo
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

View more
  8 in total

Review 1.  Human herpesvirus 6.

Authors:  D K Braun; G Dominguez; P E Pellett
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

Review 2.  Human herpesvirus-6 infections.

Authors:  C A Jones; D Isaacs
Journal:  Arch Dis Child       Date:  1996-02       Impact factor: 3.791

3.  Fatal myocarditis associated with acute parvovirus B19 and human herpesvirus 6 coinfection.

Authors:  J Rohayem; J Dinger; R Fischer; K Klingel; R Kandolf; A Rethwilm
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

4.  Interstitial pneumonitis and coinfection of human herpesvirus 6 and Pneumocystis carinii in a patient with hypogammaglobulinemia.

Authors:  Tytti Vuorinen; Pirkko Kotilainen; Irmeli Lautenschlager; Harry Kujari; Leena Krogerus; Jarmo Oksi
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

5.  Prevalence of human herpesvirus 6 in lung tissue from children with pneumonitis.

Authors:  J A Hammerling; R S Lambrecht; K S Kehl; D R Carrigan
Journal:  J Clin Pathol       Date:  1996-10       Impact factor: 3.411

6.  Prevalence of human herpesvirus 6 variant A and B infections in bone marrow transplant recipients as determined by polymerase chain reaction and sequence-specific oligonucleotide probe hybridization.

Authors:  W R Drobyski; M Eberle; D Majewski; L A Baxter-Lowe
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

Review 7.  Meningoencephalitis caused by human herpesvirus-6 in an immunocompetent adult patient: case report and review of the literature.

Authors:  D Torre; F Speranza; R Martegani; P Ferrante; E Omodeo-Zorini; R Mancuso; G P Fiori
Journal:  Infection       Date:  1998 Nov-Dec       Impact factor: 7.455

8.  Middle East Respiratory Syndrome Interpreted: Human Herpesvirus 6B Pneumonia.

Authors:  Susanna K P Lau; Jasper F W Chan; Ivan F N Hung; Vincent C C Cheng; Siddharth Sridhar; Cyril C Y Yip; Kwok-Hung Chan; Patrick C Y Woo
Journal:  Am J Med       Date:  2016-05-20       Impact factor: 4.965

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.